Drug Profile
Research programme: chemokine receptor antagonists - Celltech
Latest Information Update: 21 Sep 2007
Price :
$50
*
At a glance
- Originator Celltech Group
- Class
- Mechanism of Action Chemokine receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Inflammation; Inflammatory bowel diseases; Psoriasis
Most Recent Events
- 02 Aug 2001 Preclinical development for Inflammatory bowel disease in United Kingdom (Unknown route)
- 02 Aug 2001 Preclinical development for Psoriasis in United Kingdom (Unknown route)
- 02 May 2001 Celltech Chiroscience Discovery is now called Celltech R&D